# The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-effectiveness-of-tocilizumab-and-its-comparison-with-tumor-necrosis-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Durga Prasanna Misra,Kritika Singh,Upendra Rathore,Pallavi Patro,Alessandro Tomelleri,Corrado Campochiaro,Vikas Agarwal,Aman Sharma |
| Citations | 45 |
| DOI | 10.1016/j.autrev.2023.103275 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4317476839 |
| PMID | 36652977 |
| Type | review |
| Year | 2023 |

## Paper authors

- [Kritika Singh](https://scholariq.org/researchers/kritika-singh/)

## Paper journal

- [Autoimmunity Reviews](https://scholariq.org/journals/autoimmunity-reviews/)

## Paper primary topic

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Paper topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.